David Malcom Rodman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report) has received an average recommendation of “Buy” from the six brokerages that are presently covering the firm, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price target among brokers that have covered the stock in the last year […]

Shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report) have been assigned a consensus recommendation of “Buy” from the six analysts that are presently covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 1 year price target among brokerages that have covered the stock […]